Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

Clinical trial NCT06177171 · RECRUITING

Trial details

NCT number: NCT06177171
Sponsor: Varun Monga, MBBS
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

BRCA1 Mutation BRCA2 Mutation BRCA Mutation PALB2 Gene Mutation Checkpoint Kinase 2 Gene Mutation ATM Gene Mutation

Start date: 2024-02-07
Primary completion: 2028-01-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.